Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
Sum, Eva, Rapp, Moritz, Fröbel, Philipp, Le Clech, Marine, Dürr, Harald, Giusti, Anna Maria, Perro, Mario, Speziale, Dario, Kunz, Leo, Menietti, Elena, Brünker, Peter, Hopfer, Ulrike, Lechmann, Martin, Sobieniecki, Andrzej, Appelt, Birte, Adelfio, Roberto, Nicolini, Valeria, Freimoser-Grundschober, Anne, Jordaan, Whitney, Labiano, Sara, Weber, Felix, Emrich, Thomas, Christen, François, Essig, Birgit, Romero, Pedro, Trumpfheller, Christine, Umaña, Pablo
Published in Clinical cancer research (15.07.2021)
Published in Clinical cancer research (15.07.2021)
Get full text
Journal Article